- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02995382
Health-Related Quality of Life in Cases of Cubital Tunnel Syndrome
Health-Related Quality of Life in Cases of Anterior Intramuscular Transposition for Cubital Tunnel Syndrome: A Prospective Cohort Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
As there are many different surgical procedures to address cubital tunnel syndrome, HRQOL will be used to determine if anterior intramuscular transposition provides patients with positive outcomes. To measure HRQOL 3 specific scales will be administered:
- A generic scale, the Short Form-36
- A condition specific scale, the Patient-Rated Ulnar Nerve Evaluation (PRUNE)
- A utility scale, the EuroQOL, five dimension questionnaire
These scales are widely reported in the literature, are valid, reliable and easy to fill out. Using these scales we can determine HRQOL as well as Quality Adjusted Life Years, which, allows us to do a cost-utility analysis (economic evaluation) on this specific procedure.
Patients will be asked to fill out the above mentioned questionnaires, as well as perform 2 performance tests (grip strength, and a moving 2-point discrimination test) at the following time points:
- 1 week prior to surgery
- 1 day prior to surgery
- 3 months post surgery
- 6 months post surgery
- 12 months post surgery
Study Type
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of cubital tunnel syndrome confirmed with Electromyography (EMG) testing or Ultrasound imaging
- Ability to comprehend English and complete health related quality of life questionnaires
- Willing to provide informed consent
- Age > 18 years
- Not pregnant
Exclusion Criteria:
- Prior ipsilateral cubital tunnel release
- Evidence of symptomatic clinical double crush syndrome confirmed by EMG/Nerve Conduction Study (NCS)
- Patients with rheumatoid arthritis, connective tissue disorder, tenosynovitis, or diagnosed neurological condition that could confound the assessment of health-related quality of life with regard to the affected arm and hand
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Anterior Intramuscular Transposition
This is the only arm in our study, patients with cubital tunnel syndrome will undergo anterior intramuscular transposition, one of many surgical techniques utilized on patients with Cubital Tunnel Syndrome to alleviate symptoms.
|
Anterior intramuscular transposition technique to decompress the ulnar nerve at the level of the elbow
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Is there improvement in Health Related Quality of Life?
Time Frame: 1 week and 1 day pre-op & 3, 6, 12 months post op
|
HRQOL will be determined using 3 questionnaires: a generic widely reported scale (SF-36), a condition specific valid and reliable scale (The PRUNE), and a utility scale EuroQol-5D)
|
1 week and 1 day pre-op & 3, 6, 12 months post op
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Which Domains of Health Related Quality of Life Improve?
Time Frame: 1 week and 1 day pre-op & 3, 6, 12 months post op
|
There are different domains listed in the questionnaires, depending on the response from the patients we will determine where the improvement was seen (physical, mental, emotional, etc)
|
1 week and 1 day pre-op & 3, 6, 12 months post op
|
|
Is there improvement in physical performance?
Time Frame: 1 week and 1 day pre-op & 3, 6, 12 months post op
|
This will be measured by using grip strength and moving 2-point discrimination
|
1 week and 1 day pre-op & 3, 6, 12 months post op
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Matthew McRae, MD, McMaster University
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Nervous System Diseases
- Wounds and Injuries
- Disease
- Neuromuscular Diseases
- Mononeuropathies
- Peripheral Nervous System Diseases
- Nerve Compression Syndromes
- Cumulative Trauma Disorders
- Sprains and Strains
- Ulnar Nerve Compression Syndromes
- Ulnar Neuropathies
- Syndrome
- Cubital Tunnel Syndrome
Other Study ID Numbers
- 2016-2361
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.